Department of Endocrinology and Diabetes, Saitama Medical University, Japan.
Intern Med. 2021;60(15):2451-2459. doi: 10.2169/internalmedicine.4981-20. Epub 2021 Aug 1.
We encountered a 70-year-old Japanese woman with neurofibromatosis type 1 (NF1) who had a history of pheochromocytoma and concurrently developed adenomatous goiter, primary hyperparathyroidism, and acromegaly. The patient had a somatotroph adenoma of the adenohypophysis that predisposed her to multinodular goiter. Three parathyroid tumors were detected by cervical ultrasonography and cervicothoracic computed tomography. Genetic analyses did not reveal genetic alterations (e.g. loss-of-function mutation) in the causative genes of endocrine tumors, including MEN1, RET, VHL, CDKN1B, and CDKN2C. The NF1 gene could not be analyzed genetically due to the patient's refusal. The pathophysiologic mechanisms of endocrinopathy concurrence in NF1 remain to be elucidated.
我们遇到一位 70 岁的日本女性,患有神经纤维瘤病 1 型(NF1),曾患有嗜铬细胞瘤,并同时并发结节性甲状腺肿、原发性甲状旁腺功能亢进和肢端肥大症。该患者的腺垂体生长激素腺瘤使她易患多结节性甲状腺肿。颈部超声和颈胸 CT 检测到三个甲状旁腺瘤。基因分析未发现内分泌肿瘤相关基因(如 MEN1、RET、VHL、CDKN1B 和 CDKN2C)的遗传改变。由于患者拒绝,NF1 基因无法进行遗传分析。NF1 内分泌疾病共存的病理生理机制仍有待阐明。